ACAD - ACADIA Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 53.66B
Enterprise Value 33.09B
Trailing P/E N/A
Forward P/E 1-22.30
PEG Ratio (5 yr expected) 1-0.38
Price/Sales (ttm)15.40
Price/Book (mrq)8.76
Enterprise Value/Revenue 313.01
Enterprise Value/EBITDA 6-11.16

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -116.10%
Operating Margin (ttm)-117.81%

Management Effectiveness

Return on Assets (ttm)-41.11%
Return on Equity (ttm)-76.45%

Income Statement

Revenue (ttm)237.9M
Revenue Per Share (ttm)1.81
Quarterly Revenue Growth (yoy)28.80%
Gross Profit (ttm)18.31M
EBITDA -277.23M
Net Income Avi to Common (ttm)-276.2M
Diluted EPS (ttm)-2.10
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)414.32M
Total Cash Per Share (mrq)2.87
Total Debt (mrq)11.22M
Total Debt/Equity (mrq)2.68
Current Ratio (mrq)6.35
Book Value Per Share (mrq)2.90

Cash Flow Statement

Operating Cash Flow (ttm)-186.41M
Levered Free Cash Flow (ttm)-89.35M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.09
52-Week Change 353.25%
S&P500 52-Week Change 34.08%
52 Week High 328.67
52 Week Low 312.77
50-Day Moving Average 325.33
200-Day Moving Average 323.23

Share Statistics

Avg Vol (3 month) 31.07M
Avg Vol (10 day) 3839.97k
Shares Outstanding 5144.17M
Float 104.65M
% Held by Insiders 10.30%
% Held by Institutions 198.72%
Shares Short (May 31, 2019) 412.25M
Short Ratio (May 31, 2019) 412.06
Short % of Float (May 31, 2019) 414.82%
Short % of Shares Outstanding (May 31, 2019) 48.50%
Shares Short (prior month Apr 30, 2019) 411.18M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A